Total Payments
$6,396
2024 Payments
$125.00
Companies
25
Transactions
65
Medicare Patients
1,401
Medicare Billing
$137,129
Payment Breakdown by Category
Other$3,750 (58.6%)
Food & Beverage$2,435 (38.1%)
Education$210.99 (3.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Grant | $3,750 | 2 | 58.6% |
| Food and Beverage | $2,435 | 60 | 38.1% |
| Education | $210.99 | 3 | 3.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Cook Medical LLC | $2,623 | 4 | $0 (2023) |
| Cook Incorporated | $1,295 | 2 | $0 (2018) |
| ABBVIE INC. | $455.15 | 17 | $0 (2023) |
| Lucid Diagnostics Inc. | $295.37 | 4 | $0 (2023) |
| GENZYME CORPORATION | $247.89 | 4 | $0 (2023) |
| Endogastric Solutions, Inc | $174.74 | 4 | $0 (2023) |
| Janssen Biotech, Inc. | $161.66 | 3 | $0 (2023) |
| CONMED Corporation | $150.23 | 1 | $0 (2021) |
| E.R. Squibb & Sons, L.L.C. | $127.53 | 1 | $0 (2023) |
| Ardelyx, Inc. | $125.00 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $125.00 | 1 | Ardelyx, Inc. ($125.00) |
| 2023 | $1,049 | 21 | Lucid Diagnostics Inc. ($295.37) |
| 2022 | $286.83 | 9 | ABBVIE INC. ($164.33) |
| 2021 | $232.92 | 3 | CONMED Corporation ($150.23) |
| 2020 | $106.71 | 5 | Ambu Inc. ($41.10) |
| 2019 | $233.03 | 9 | AbbVie, Inc. ($159.96) |
| 2018 | $2,822 | 10 | Cook Medical LLC ($2,505) |
| 2017 | $1,542 | 7 | Cook Incorporated ($1,250) |
All Payment Transactions
65 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/21/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/04/2023 | ABBVIE INC. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $23.70 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/24/2023 | Endogastric Solutions, Inc | ESOPHYX (Device) | Food and Beverage | Cash or cash equivalent | $10.90 | General |
| Category: GERD | ||||||
| 11/10/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $2.97 | General |
| Category: Immunology | ||||||
| 10/31/2023 | Lucid Diagnostics Inc. | — | Food and Beverage | In-kind items and services | $95.31 | General |
| 10/18/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $13.41 | General |
| Category: Neuroscience | ||||||
| 10/17/2023 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 09/19/2023 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 08/16/2023 | Lucid Diagnostics Inc. | — | Food and Beverage | In-kind items and services | $14.67 | General |
| 08/03/2023 | Lucid Diagnostics Inc. | — | Food and Beverage | In-kind items and services | $105.10 | General |
| 08/02/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $14.23 | General |
| Category: Neuroscience | ||||||
| 06/29/2023 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Food and Beverage | In-kind items and services | $23.25 | General |
| Category: INTERNAL MEDICINE | ||||||
| 06/22/2023 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $22.79 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/05/2023 | Enterra Medical, Inc. | — | Food and Beverage | Cash or cash equivalent | $88.32 | General |
| 05/31/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $96.41 | General |
| Category: Immunology | ||||||
| 05/18/2023 | E.R. Squibb & Sons, L.L.C. | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $127.53 | General |
| Category: Neuroscience | ||||||
| 05/18/2023 | Cook Medical LLC | ECHOTIP (Device) | Food and Beverage | Cash or cash equivalent | $69.04 | General |
| Category: Endoscopy | ||||||
| 05/17/2023 | Merck Sharp & Dohme LLC | DIFICID (Drug), ZINPLAVA | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 04/13/2023 | Lucid Diagnostics Inc. | — | Food and Beverage | In-kind items and services | $80.29 | General |
| 04/12/2023 | Endogastric Solutions, Inc | ESOPHYX (Device) | Food and Beverage | Cash or cash equivalent | $76.96 | General |
| Category: GERD | ||||||
| 03/14/2023 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $19.67 | General |
| Category: Immunology | ||||||
| 01/26/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $117.03 | General |
| Category: Immunology | ||||||
| 12/07/2022 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Food and Beverage | In-kind items and services | $21.25 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/17/2022 | Endogastric Solutions, Inc | ESOPHYX (Device) | Food and Beverage | Cash or cash equivalent | $27.02 | General |
| Category: GERD | ||||||
| 09/01/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $121.09 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 367 | 377 | $196,965 | $37,302 |
| 2022 | 11 | 318 | 327 | $142,284 | $30,182 |
| 2021 | 13 | 419 | 430 | $186,481 | $40,316 |
| 2020 | 10 | 297 | 319 | $126,590 | $29,329 |
Total Patients
1,401
Total Services
1,453
Medicare Billing
$137,129
Procedure Codes
47
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 71 | 72 | $69,048 | $13,044 | 18.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 36 | 37 | $15,059 | $4,857 | 32.3% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 51 | 54 | $28,674 | $3,683 | 12.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 39 | 39 | $12,285 | $3,337 | 27.2% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 33 | 33 | $17,655 | $2,453 | 13.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 20 | 21 | $6,077 | $1,892 | 31.1% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 14 | 14 | $9,576 | $1,843 | 19.3% |
| 91010 | Study of esophagus to assess movement | Facility | 2023 | 29 | 29 | $7,714 | $1,406 | 18.2% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 19 | 19 | $15,295 | $1,197 | 7.8% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2023 | 11 | 11 | $8,030 | $1,087 | 13.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 14 | 18 | $2,682 | $1,077 | 40.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 14 | 14 | $2,886 | $837.43 | 29.0% |
| 91037 | Monitoring and recording of esophageal function through nasal tube with electrode | Facility | 2023 | 16 | 16 | $1,984 | $587.36 | 29.6% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 47 | 47 | $45,613 | $8,164 | 17.9% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 56 | 57 | $15,789 | $5,573 | 35.3% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 46 | 49 | $26,215 | $4,089 | 15.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 27 | 27 | $10,989 | $3,790 | 34.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 26 | 26 | $8,190 | $2,438 | 29.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 33 | 34 | $5,066 | $1,757 | 34.7% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 21 | 22 | $11,682 | $1,559 | 13.3% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 14 | 14 | $11,270 | $930.97 | 8.3% |
| 91010 | Study of esophagus to assess movement | Facility | 2022 | 15 | 15 | $3,990 | $754.05 | 18.9% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 21 | 24 | $1,992 | $671.36 | 33.7% |
| 91037 | Monitoring and recording of esophageal function through nasal tube with electrode | Facility | 2022 | 12 | 12 | $1,488 | $455.96 | 30.6% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 80 | 80 | $22,294 | $8,073 | 36.2% |
About Dr. Diego Lim, MD
Dr. Diego Lim, MD is a Internal Medicine healthcare provider based in Greenville, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/18/2012. The National Provider Identifier (NPI) number assigned to this provider is 1699038505.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Diego Lim, MD has received a total of $6,396 in payments from pharmaceutical and medical device companies, with $125.00 received in 2024. These payments were reported across 65 transactions from 25 companies. The most common payment nature is "Grant" ($3,750).
As a Medicare-enrolled provider, Lim has provided services to 1,401 Medicare beneficiaries, totaling 1,453 services with total Medicare billing of $137,129. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine, Gastroenterology
- Location Greenville, SC
- Active Since 06/18/2012
- Last Updated 09/18/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1699038505
Products in Payments
- DUPIXENT (Biological) $247.89
- ESOPHYX (Device) $174.74
- ZEPOSIA (Drug) $155.17
- CONMED BILIARY (Device) $150.23
- REMICADE (Biological) $141.99
- STELARA (Biological) $133.52
- IBSRELA (Drug) $125.00
- SKYRIZI (Biological) $121.09
- Humira (Biological) $104.94
- XELJANZ (Drug) $87.14
- ECHOTIP (Device) $69.04
- PillCam (Device) $69.00
- GENERAL HEMOSTASIS (Device) $53.82
- COOK MEDICAL HEMOSPRAY (Device) $50.16
- Cook Medical Biliary (Device) $49.29
- GATTEX (Drug) $44.50
- Mulpleta (Drug) $33.09
- RESOLUTION CLIP (Device) $27.60
- LINZESS (Drug) $25.38
- VIBERZI (Drug) $23.70
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Greenville
Stephen Dyar, Md, MD
Internal Medicine — Payments: $381,835
Internal Medicine $381,835
Dr. John Catanzaro, Md, MD
Internal Medicine — Payments: $331,996
Internal Medicine $331,996
Bhumika Patel, M.d, M.D
Internal Medicine — Payments: $208,547
Internal Medicine $208,547
Dr. Thomas Gallaher, M.d, M.D
Internal Medicine — Payments: $208,355
Internal Medicine $208,355
Bruce Gray, D.o, D.O
Internal Medicine — Payments: $166,102
Internal Medicine $166,102
Dr. Mark Purcell, Do, DO
Internal Medicine — Payments: $135,587
Internal Medicine $135,587